Alto Neuroscience (ANRO) Retained Earnings (2023 - 2026)

Alto Neuroscience has reported Retained Earnings for 4 years, with the latest figure at $13000.0 in Q1 2026.

• Quarterly Retained Earnings fell 7.14% year-over-year to $13000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13000.0 (down 7.14% YoY) and the FY2025 annual result came in at $352.8 million, up 354.89% from the prior year.
• Retained Earnings declined to $13000.0 in Q1 2026 per ANRO's latest filing, from $352.8 million in the prior quarter.
• Over five years, Retained Earnings peaked at $352.8 million in Q4 2025 and troughed at -$185.5 million in Q3 2025.
• A 4-year average of -$7.0 million and a median of -$45.2 million in 2023 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings tumbled 175084.81% in 2024, then surged 354.89% in 2025.
• Over 4 years, Retained Earnings stood at -$79000.0 in 2023, then sank by 175084.81% to -$138.4 million in 2024, then soared by 354.89% to $352.8 million in 2025, then slumped by 100.0% to $13000.0 in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $13000.0, $352.8 million, and -$185.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.